Company Description
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States.
It operates through two segments, Healthcare Services and Pharmacy.
The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center.
This segment also provides information technology services; and owns unimproved lands.
The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services.
SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
Country | United States |
IPO Date | Mar 18, 1980 |
Industry | Medical - Pharmaceuticals |
Sector | Healthcare |
Employees | 1,376 |
CEO | Robert M. Thornton Jr. |
Contact Details
Address: 900 Circle 75 Parkway Atlanta, Georgia United States | |
Website | https://www.sunlinkhealth.com |
Stock Details
Ticker Symbol | SSY |
Exchange | AMEX |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | 0000096793 |
CUSIP Number | 86737U102 |
ISIN Number | US86737U1025 |
Employer ID | 31-0621189 |
SIC Code | 8062 |
Key Executives
Name | Position |
---|---|
Robert M. Thornton Jr. | Executive Chairman, Chief Executive Officer & President |
Mark J. Stockslager | Chief Financial Officer, Principal Accounting Officer & Director |
Byron D. Finn CPA | President of SunLink ScriptsRX, LLC & Carmichaels Cashway Pharmacy Inc |
James J. Mulligan | General Counsel & Director Emeritus |
Neal Miller | President of SunLink HealthCare Technology, Inc |
Sheila G. Brockman | Vice President |
Theresa Mota | Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 12, 2024 | 10-Q | Quarterly Report |
Oct 25, 2024 | 10-K/A | [Amend] Annual Report |
Oct 18, 2024 | 8-K | Current Report |
Sep 30, 2024 | 10-K | Annual Report |
Jul 24, 2024 | 8-K | Current Report |
Jul 12, 2024 | 8-K | Current Report |
Jun 07, 2024 | ARS | Filing |
Jun 06, 2024 | DEF 14A | Filing |
Jun 05, 2024 | 8-K | Current Report |
May 23, 2024 | 8-K/A | [Amend] Current Report |